ClinicalTrials.Veeva

Menu

Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy

S

Shandong University

Status

Completed

Conditions

Colorectal Adenoma
Colorectal SSA
Colorectal Polyp
Colorectal Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT05576506
2022-SDU-QILU-G003

Details and patient eligibility

About

The purpose of this study is to develop and validate a deep learning algorithm for the diagnosis of colorectal cancer other colorectal disease by marking and analyzing the characteristics of hyperspectral images based on the pathological results of colonoscopic biopsy, so as to improve the objectiveness and intelligence of early colorectal cancer diagnosis.

Full description

Prospectively collect the hyperspectral image information of ordinary colonoscopic biopsy tissue. The colonoscopic biopsy tissue is from the Endoscopy Center of Qilu Hospital of Shandong University. The hyperspectral images are marked based on the biopsy pathological results, and the deep convolutional neural network (DCNN) model is used. With training and verification, develop the Hyperspectral Imaging Artificial Intelligence Diagnostic System (HSIAIDS) .A portion of colonoscopic biopsy tissue will be collected as a prospective test set to prospectively test the diagnostic performance of the HSIAIDS algorithm.

Enrollment

86 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients aged 18-75 years who undergo the colonoscopy examination and biopsy

Exclusion criteria

  • patients with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who cannot participate in colonoscopy
  • patients with previous surgical procedures on the gastrointestinal tract.
  • patients with contraindications to biopsy
  • patients who refuse to sign the informed consent form

Trial design

86 participants in 1 patient group

Deep learning algorithm group
Description:
After the patient has passed the screening, a routine colonoscopy will be performed, and the target tissue with suspected inflammation or neoplasia will be biopsied. The clinical investigators use the hyperspectral microscope to collect image information of the biopsy tissue in the endoscopy room. After collecting information, biopsy specimens will be routinely processed and sent for pathological diagnosis.

Trial contacts and locations

1

Loading...

Central trial contact

Xiuli Zuo, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems